Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Tipos de Cancer / / Cáncer de la Laringe / Recursos de NCI
|
NCI CANCERLIT® Search: Laryngeal Cancer - October 2001
Quality of life after treatment for early laryngeal carcinoma. [Microlaryngoscopy treatment of laryngeal dysplasia with CO2 laser] Microsatellite and chromosome instability in squamous cell laryngeal carcinoma. Results of salvage surgery for... |
|
|
NCI CANCERLIT® Search: Laryngeal Cancer - September 2001
Table of Contents[Antibiotic prophylaxis in oncologic pharyngolaryngeal surgery: ceftriaxone versus clindamycin and gentamycin]Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San... |
|
|
NCI CANCERLIT® Search: Laryngeal Cancer - April 2002
PTEN and LKB1 genes in laryngeal tumours. [Homozygous deletion of p16 and p15 genes in laryngeal squamous cell carcinoma] [The relationship of p53 gene mutation to cell differentiation and metastasis of laryngeal squamous cell carcinoma]... |
|
|
NCI CANCERLIT® Search: Laryngeal Cancer - August 2002
Neuroendocrine neoplasms of the larynx: diagnosis, treatment and prognosis. Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer. Supraglottic carcinoma: patterns... |
|
|
NCI CANCERLIT® Search: Laryngeal Cancer - February 2002
[Long-term results of total versus partial laryngectomy for the treatment of squamous-cell carcinoma of the larynx] Inducible nitric oxide synthase expression in laryngeal neoplasia: correlation with angiogenesis. Evaluation of a leaf... |
|
|
NCI CANCERLIT® Search: Laryngeal Cancer - January 2002
Organ preservation for carcinoma of the larynx and hypopharynx. Conservation laryngeal surgery for malignant tumors of the larynx and pyriform sinus. Positive surgical margins in cancer of the larynx. Nuclear texture features for classifying... |
|
|
NCI CANCERLIT® Search: Laryngeal Cancer - July 2002
[Studies of the deletion and expression of cytokeratin 13 gene in laryngeal squamous cell carcinoma] External versus endoscopic approach in the surgical treatment of glottic cancer. Prognostic value of the expression of p53 and bcl-2 in... |
|
|
NCI CANCERLIT® Search: Laryngeal Cancer - June 2002
P53 tumor suppressor gene mutations in laryngeal cancer and in recurrent disease following radiation therapy. [Cancers of the larynx: what therapeutic strategy to use in Senegal?] Is radiotherapy recommended after supraglottic laryngectomy? ... |
|
|
NCI CANCERLIT® Search: Laryngeal Cancer - March 2002
Positive impact of retinyl palmitate in leukoplakia of the larynx. The significance of pre-epiglottic space invasion in supraglottic laryngeal carcinomas. Detection and localization of early laryngeal cancer with laser-induced ... |
|
|
NCI CANCERLIT® Search: Laryngeal Cancer - May 2002
Intraoperative management of the thyroid gland in laryngeal cancer surgery. Induction of the CBP transcriptional co-activator early during laryngeal carcinogenesis. Results of radiotherapy for primary subglottic squamous cell carcinoma.... |
|
|
NCI CANCERLIT® Search: Laryngeal Cancer - October 2002
Carcinoma larynx--topographical distribution. The pattern of expression of Mn and Cu-Zn superoxide dismutase varies among squamous cell cancers of the lung, larynx, and oral cavity. Analysis of local recurrence in patients with selected... |
|
|
NCI CANCERLIT® Search: Laryngeal Cancer - September 2002
Smokeless tobacco use and cancer of the upper respiratory tract. Female laryngectomees' satisfaction with communication methods and speech-language pathology services. Total laryngectomy: pre- and intrasurgical variables of infection risk. ... |
|
|
NCI/PDQ® Health professionals: Laryngeal Cancer Treatment (PDQ®)
TABLE OF CONTENTS General Information About Laryngeal CancerIncidence and MortalityCellular Classification of Laryngeal CancerStage Information for Laryngeal CancerDefinitions of TNMTreatment Option OverviewStage I Laryngeal... |
|
|
NCI/PDQ® Pacientes: Cáncer de la laringe
TABLE OF CONTENTS Descripción¿Qué es cáncer de la laringe?Explicación de los estadiosEstadios del cáncer de la laringeEstadio IRegión supraglóticaGlotisRegión subglóticaEstadio IIRegión... |
|
|
NCI/PDQ® Patients: Laryngeal Cancer Treatment (PDQ®)
TABLE OF CONTENTS General Information About Laryngeal CancerStages of Laryngeal CancerRecurrent Laryngeal CancerTreatment Option OverviewTreatment Options by Stage Stage I Laryngeal CancerStage II Laryngeal CancerStage III Laryngeal CancerStage IV... |
|
|
NCI/PDQ® Profesionales De Salud: Cáncer de la laringe: Tratamiento (PDQ®)
TABLE OF CONTENTS Información general sobre el cáncer de la laringeIncidencia y MortalidadClasificación celular del cáncer de la laringeInformación sobre los estadios del cáncer de la laringeDefiniciones TNMAspectos... |
Ms. Wagner discusses diet during cancer treatment and balancing nutritional needs and side effects. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

